Home › Major Depressive Disorder › Alabama › Huntsville
Major Depressive Disorder clinical trials in Huntsville, AL
6 studies for Major Depressive Disorder are looking for participants at sites in and around Huntsville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
RecruitingPhase 3
- University of Alabama at Birmingham, Huntsville
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecruitingPhase 3
- University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Huntsville
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Huntsville
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RecruitingHealthy volunteers welcome
- UAB Huntsville Regional Medical Campus, Huntsville
MicroRNA Correlates of Childhood Maltreatment and Suicidality
RecruitingObservational studyHealthy volunteers welcome
- UAB Huntsville Regional Medical Campus, Huntsville
Major Depressive Disorder trials in other cities
- New York City, NY36 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Chicago, IL17 studies
- Tampa, FL17 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Huntsville
- Cardiovascular Disease8 studies
- Obesity7 studies
- Coronary Artery Disease6 studies
- Heart Failure6 studies
- Type 2 Diabetes6 studies
- Depression6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Aortic Valve Stenosis4 studies
- Chronic Kidney Disease4 studies
- Heart Attack3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.